Compax Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 27-06-2024
- Paid Up Capital ₹ 0.28 M
as on 27-06-2024
- Company Age 44 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 9.03%
(FY 2022)
- Profit 2968.80%
(FY 2022)
- Ebitda 39.90%
(FY 2022)
- Net Worth 6.88%
(FY 2022)
- Total Assets 4.38%
(FY 2022)
About Compax Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.28 M, as per Ministry of Corporate Affairs (MCA) records.
Radha Borawake and Shila Rathi serve as directors at the Company.
- CIN/LLPIN
U33119MH1980PTC022183
- Company No.
022183
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Feb 1980
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Compax Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Radha Borawake  | Director | 08-Nov-2021 | Current |
| Shila Rathi | Director | 21-May-1988 | Current |
Financial Performance of Compax Laboratories.
Compax Laboratories Pvt Ltd, for the financial year ended 2022, experienced modest growth in revenue, with a 9.03% increase. The company also saw a substantial improvement in profitability, with a 2968.8% increase in profit. The company's net worth moved up by a moderate rise of 6.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Compax Laboratories?
In 2020, Compax Laboratories had a promoter holding of 99.96% and a public holding of 0.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Compax Laboratories?
Unlock and access historical data on people associated with Compax Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Compax Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Compax Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
